N
Nectar Lifesciences
NECLIFE Share Price
Healthcare11.35
as on 10 Mar 2026 at 15:53
Market Cap
₹220 Cr
PE Ratio
-0.60
ROCE
-8.48%
NECLIFE Fundamentals
Company Valuation
Market Cap (₹ Cr.)
220
PE Ratio
-0.60
PB Ratio
0.31
Dividend Yield
-
ROE
-11.89%
ROCE
-8.48%
Book Value (₹)
36.75
Face Value (₹)
1.00
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Jan 2026 |
|---|---|---|---|---|---|
| Promoters | 44.53% | 44.53% | 44.91% | 44.91% | 51.84% |
| Domestic Institutional Investors (DII) | 0.16% | 0.19% | 0.09% | 5.82% | 3.54% |
| Foreign Institutional Investors (FII) | 1.65% | 0.81% | 0.62% | 0.52% | 0.58% |
| Public Investors | 41.60% | 44.12% | 44.70% | 39.72% | 35.83% |
| Government | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
NECLIFE Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
532649
NSE Scrip Name
NECLIFE
ISIN
INE023H01027



